Skip to main content
. 2022 Jul 6;57(10):1520–1530. doi: 10.1038/s41409-022-01739-x

Table 2.

Patient list and indication for allo-HSCT.

Patient ID/gender PID subtype PID name Gene Age at first symptoms/ clinical diagnosis (years) Main complications before allo-HSCT Indication for allo-HSCT
UPN 1/M CID CID RAG 1 10/10 Recurrent bacterial infections (ULRTI/meningitis)/colitis/LPD. Splenectomy Worsening pancytopenia
UPN 2/M PIRD ALPS TNFRSF 5/16 Recurrent AI cytopenia. Splenomegaly. Splenectomy Refractory pancytopenia
UPN 3/M PIRD IDR with colitis IL10RB 1/15 Relapsing DLBCL. Colitis DLBCL (CR4)
UPN 4/M CID XL-HIGM CD40L 1/2 Recurrent bacterial infections (ULRTI). Toxoplasmosis. Cholangitis. Cryptosporidium cholangitis
UPN 5/M CID WAS WASP 2/3 Recurrent bacterial infections (ULRTI). Vasculitis. AI cytopenia. DLBCL. Splenectomy DLBCL (CR1)
UPN 6/M CID WAS WASP 1/3 Recurrent bacterial infections (ULRTI). Vasculitis. Nephropathy. Renal transplantation Vasculitis
UPN 8/M CID MST1 deficiency MST1 6/8 Recurrent bacterial infections (ULRTI). Disseminated moluscum Worsening moluscum
UPN 9/M CID XL-HIGM CD40L 0/0 Recurrent bacterial infections (ULRTI). PJP. Cholangitis Cryptosporidium cholangitis
UPN 11/M CID CID CD3E 0/1 Recurrent bacterial infections (ULRTI). DLBCL DLBCL (CR1)
UPN 12/M CID APDS-1 PIK3CD 1/4 Recurrent bacterial infections (ULRTI). AI cytopenia. Disseminated VZV. Splenectomy Disseminated VZV
UPN 13/M PIRD unk unk 0/9 Recurrent bacterial infections (ULRTI). AI cytopenia Refractory pancytopenia
UPN 14/M CID WAS WASP 1/2 Recurrent bacterial infections (ULRTI). Vasculitis. AI cytopenia. Splenectomy Vasculitis
UPN 15/F CID CID PRKDC 1/9 Recurrent bacterial infections (ULRTI). IFI. Arthritis. DLBCL DLBCL (CR1)
UPN 16/M Phag CGD CYB 1/1 IFI CNS IA
UPN 17/M Phag CGD CYB 11/11 IFI. Colitis. IA
UPN 18/M CID WAS WASP 0/0 Recurrent bacterial infections (ULRTI). AI cytopenia. Arthritis Disseminated moluscum. DLBCL. Splenectomy DLBCL (CR1)
UPN 19/M CID CID unk 0/1 Recurrent bacterial infections (ULRTI). Recurrent EBV reactivation. HLH. Relapsing DLBCL DLBCL (CR2)
UPN 20/F CID CID unk 34/35 Recurrent bacterial infections (ULRTI). Recurrent EBV T cell LPD EBV positive T cell LPD
UPN 21/M PIRD PIRD unk 18/18 Recurrent bacterial and fungal infection. Recurrent AI neutropenia. Recurrent T cell LPD. Refractory neutropenia
UPN 22/M PIRD XLP-1 SH2D1A 11/11 Recurrent bacterial infections (ULRTI). Severe aplastic anemia. Liver nodular regenerative hyperplasia. Recurrent EBV LPD. BL. Recurrent EBV LPD
UPN 23/M CID XL-HIGM CD40L 0/5 Recurrent bacterial infections (ULRTI). Toxoplasmosis. Cholangitis Cryptosporidium cholangitis
UPN 24/M CID ADA deficiency ADA 1/1 Recurrent bacterial infections (ULRTI). Recurrent EBV HL. Liposarcoma Recurrent EBV HL (CR2)
UPN 25/M Phag CGD CYB 3/3 IFI lung and cardiac IA
UPN 26/M Phag CGD CYB 2/2 IFI Lung IA
UPN 27/M CID CID unk 2/3 Recurrent bacterial infections (ULRTI). AI cytopenia. Recurrent T cell LPD. Splenectomy Refractory neutropenia
UPN 28/M CID CID unk 2/3 Recurrent bacterial infections (ULRTI). Meningitis. Colitis Refractory colitis
UPN 29/M PIRD XLP-1 SH2D1A 4/4 Recurrent bacterial infections (ULRTI). HLH. AI neutropenia. Refractory neutropenia
UPN 30/M Phag CGD CYB 5/5 Recurrent bacterial and fungal infections. Actinomycosis. Colitis Actynomycosis
UPN 31/M Phag CGD CYB 2/2 Recurrent bacterial and fungal infections. Inflammatory myopericarditis Inflammatory myopericarditis
UPN 32/M Phag CGD CYB 1/1 Recurrent bacterial and fungal infections. HLH IFI. HLH
UPN 33/M Phag CGD CYB 14/14 Recurrent bacterial and fungal infections. Colitis. ILD ILD
UPN 34/M Phag CGD CYB 6/7 Recurrent bacterial and fungal infections. Lung and thyroid IA

APDS Activated PI3K delta syndrome, ALPS autoimmune lymphoproliferative syndrome, AI autoimmune, CID combined immunodeficiency, CGD Chronic granulomatous disease, CR complete remission, CMV cytomegalovirus, DLBCL diffuse large B-cell lymphoma, EBV Epstein Barr virus, HLH Hemophagocytic lymphohistiocytosis, IDR Immune deregulation, IFI invasive fungal infection, IA invasive aspergillosis, ILD Interstitial lung disease, LPD lymphoproliferative disease, PIRD primary immune regulation disorders, Phag phagocyte impairment, PJP Pneumocystis jirovecii Pneumonia, ULRTI upper and low respiratory tractus infection, Unk unknown, VZV varicella-zoster virus, WAS Wiskott–Aldrich syndrome, XL-HIGM X-linked hyper IgM syndrome, XLP-1 X-linked lymphoproliferative disease type 1.